Iranian
Biomedical Journal
Volume 30, Issue 1 (1-2026)
IBJ 2026, 30(1): 36-46 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hasanian-Langroudi F, Hedayati M, Esmaeili F, Tohidi M, Siadat S D. Bacteroides thetaiotaomicron and Human Health: A Bibliometric Analysis of Global Research Trends. IBJ 2026; 30 (1) :36-46
URL: http://ibj.pasteur.ac.ir/article-1-5097-en.html
URL: http://ibj.pasteur.ac.ir/article-1-5097-en.html
Farzaneh Hasanian-Langroudi 
, Mehdi Hedayati , Farzad Esmaeili , Maryam Tohidi , Seyed Davar Siadat *
, Mehdi Hedayati , Farzad Esmaeili , Maryam Tohidi , Seyed Davar Siadat *
Abstract:
Bacteroides thetaiotaomicron is a highly abundant Gram-negative anaerobic bacterium that plays a crucial role in maintaining intestinal homeostasis and modulating intestinal diseases. A bibliometric study was conducted to examine global publication trends on B. thetaiotaomicron, using the Scopus database and scientific metrics software over the period 1965-2024. The study investigated variables such as publication year, reference numbers, article type, country, language, and author affiliation. Among the 2,510 articles reviewed on B. thetaiotaomicron, findings indicated that inflammatory bowel disease was the most frequently studied condition. The journal “Anaerobe” published the highest number of articles (n = 68). The United States ranked as the leading country, contributing 969 publications. A total of 14 languages were used in the publications, with 96% written in English. Given the increasing prevalence of digestive diseases and the need for more effective treatments than conventional therapies, B. thetaiotaomicron could be considered a promising therapeutic candidate.
Type of Study: Review Article |
Subject:
Molecular Microbiology
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |